 |
1 Product |  |
0 Diseases | | 1 Product |
|
0 Trials |  |
3 News |  |
- | diepalrestat choline (BNV-222) / NeuroMax, BioNevia
Trial completion, Trial primary completion date: 12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study (clinicaltrials.gov) - Sep 27, 2018
P2/3, N=330, Completed, Sponsor: NeuromaxBionevia
Recruiting --> Completed | Trial primary completion date: Mar 2017 --> Nov 2017
- |||| diepalrestat choline (BNV-222) / NeuroMax, BioNevia
Trial primary completion date: 12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study (clinicaltrials.gov) - Dec 5, 2015
P2/3, N=330, Recruiting, Sponsor: NeuromaxBionevia
Recruiting --> Completed | Trial primary completion date: Mar 2017 --> Nov 2017 Trial primary completion date: Jul 2016 --> Mar 2017
- || diepalrestat choline (BNV-222) / NeuroMax, BioNevia
New P2/3 trial: 12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study (clinicaltrials.gov) - Jan 6, 2015
P2/3, N=330, Recruiting, Sponsor: NeuromaxBionevia